Which State Is Ranked #1 For Lithium Investors?
The Fraser Institute ran a survey to find the best spot in the world for lithium mining. They researched 77 spots from around the world… and the Nevada Desert won the #1 spot by a landslide. And this small mining company just staked 11,700 acres of mineral claims in Nevada's hottest lithium spot...
See Why This Lithium Stock Could Explode

BOT Insider Trading (Botanix Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Botanix Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Botanix Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Botanix Pharmaceuticals Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for BOT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
This Options Expert is Giving Everything Away!
Trading champion Chuck Hughes has exposed the strategies of successful traders and handing them over to new traders like you!

His guide “Options Trading Made Easy” now comes with a Trade of the Day from Chuck himself to help you develop a profitable, pro-level trading account!
Get your copy today!

Botanix Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/22/2022Daniel SharpInsiderIssued5,000,000A$0.07A$355,000.00
2/21/2022Stewart WasherInsiderExpiry4,000,000A$0.06A$232,000.00
6/30/2020Stewart WasherInsiderIssued4,863,490A$0.04A$189,676.11
5/8/2020Michael ThurnInsiderExpiry2,882,837A$0.05A$129,727.67
2/21/2020Stewart WasherInsiderExpiry1,000,000A$0.09A$88,000.00
12/10/2019Michael ThurnInsiderExercise1,000,000A$0.09A$90,000.00
12/2/2019H. William BoschInsiderExercise500,000A$0.07A$34,000.00
7/18/2019Michael ThurnInsiderIssued5,000,000A$0.23A$1,125,000.00
See Full Table
What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"

SEC Filings (Institutional Ownership Changes) for Botanix Pharmaceuticals (ASX:BOT)

Botanix Pharmaceuticals logo
Botanix Pharmaceuticals Limited, a clinical stage synthetic cannabinoid pharmaceutical company, engages in the research and development of dermatology and antimicrobial products in Australia. Its product pipeline include BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIa clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase Ib clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in North Perth, Australia.
Read More on Botanix Pharmaceuticals

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


1,627,221 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Botanix Pharmaceuticals?

Botanix Pharmaceuticals' top insider investors include:
  1. Daniel Sharp (Insider)
  2. Stewart Washer (Insider)
Learn More about top insider investors at Botanix Pharmaceuticals.
Better Options For Trading!
I know–you’ve heard options trading is tough, but is it really tougher than the market is right now?

NO! “Options Trading Made Easy” by pro-trader Chuck Hughes gives traders the best options in an unpredictable market…

Get your copy now!